Tag: Pancreas
Search News
Foot-and-mouth-disease virus could help target pancreatic cancer
12th February 2020
Researchers at Barts Cancer Institute, Queen Mary University of London, have identified a peptide, or protein fragment, taken from the foot-and-mouth-disease virus that targets another protein, called avβ6 (alpha-v-beta-6). This protein is found at high levels on the surface of the majority of pancreatic cancer cells.
Read more
First steps towards a vaccine for pancreatic cancer
26th November 2019
Researchers from Barts Cancer Institute and Zhengzhou University have developed a personalised vaccine system that could ultimately delay the onset of pancreatic cancer. The study reports the team’s work with a pre-clinical model using mice, and provides strong proof-of-concept for the creation of a vaccine for cancer prevention in individuals at high risk of developing this disease.
Read more
World Pancreatic Cancer Day 2019
21st November 2019
This World Pancreatic Cancer Day, hear from some of our researchers about what they are working on to help combat this devastating cancer type.
Read more
Breaking down the barrier
22nd October 2019
The Medical Research Council has awarded Dr Godinho a £600,000 project grant to fund vital research on pancreatic cancer, that will investigate ways to tackle the impenetrable barrier that surrounds pancreatic tumours, in the hope of identifying targets for therapeutic intervention.
Read more
Urine test for pancreatic cancer starts clinical study
25th September 2019
A urine test that can detect early stage pancreatic cancer has reached the final stage of validation before being developed for use with patients. If successful, this non-invasive urine test would be the first in the world to help clinicians detect the highly lethal cancer at an early stage – enabling many more people to have surgery to remove their tumour, which is currently the only potentially curative treatment.
Read more
Antibody therapy in pancreatic cancer
31st July 2019
Scientists have found a way to target and knock out a single protein that they have discovered is widely involved in pancreatic cancer cell growth, survival and invasion. Called avb6, the protein is present on the surface of more than 80 per cent of pancreatic ductal adenocarcinoma – the most common form of pancreatic cancer – and is vital to increase the successful growth and spread of the tumour cells.
Read more